Author:
Kerpel-Fronius Sandor,Kurihara Chieko,Crawley Francis P.,Baroutsou Varvara,Becker Sander,Franke-Bray Brigitte,Matsuyama Kotone,Naseem Shehla,Schenk Johanna
Abstract
This paper discusses the effects of armed conflict, economic sanctions, and natural catastrophes on ongoing clinical trials. We suggest that• stopping the accrual of new patients in clinical trials under such extreme conditions is acceptable.• research participants already receiving trial medication in such disruptive situations are to be considered highly vulnerable due to their medical dependency for ongoing treatment according to the approved clinical study protocol.• based on the present experience in Ukraine and Russia, we conclude that finishing ongoing trial treatments according to approved or amended protocols should be considered to be an ethical obligation of trial sponsors irrespective whether trial disruption is due to war, economic sanctions, or natural catastrophes.• it is important to devote more attention to the ethical challenges raised by such fundamentally disruptive situations to clinical trials generally in any region of the world.
Reference19 articles.
1. Investigational Drug Supply for Seriously ill Patients in Time of War. IFAPP TODAY. No 23
2. Clinical trials during war in Ukraine;Rubin;JAMA.,2022
3. 2022
4. “The war puts ukraine's clinical trials—and patients—in Jeopardy,”Hundreds of trials have been disrupted in the medical research hub. Some patients are at risk of losing their last chance at survival. Science2022
5. Catastrophic health consequences of the war in Ukraine;Fontanarosa;JAMA.,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献